Join
Live feed
·
PRReleasevia Quantisnow
TuHURA Biosciences Inc. logo
Kintara Therapeutics Inc. logo

Craig Tendler, M.D., JNJ's Former Global Head of Oncology Clinical Development, to Lead TuHURA Bioscience's VISTA Program in AML and other Blood Related Cancers

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track HURA (TuHURA Biosciences Inc.), KTRA (Kintara Therapeutics Inc.) and more on Quantisnow.